Postmenopausal hormone therapy and the risk of cardiovascular disease: the epidemiologic evidence
- 1 July 2002
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 90 (1) , F26-F29
- https://doi.org/10.1016/s0002-9149(01)02219-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study: A Prospective, Observational StudyAnnals of Internal Medicine, 2001
- Postmenopausal Hormone Therapy and Risk of StrokeCirculation, 2001
- A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular DiseaseAnnals of Internal Medicine, 2000
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease and Hip Fracture in a Cohort of Swedish WomenEpidemiology, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONSAnnual Review of Public Health, 1998
- Ischemic Stroke and Use of Estrogen and Estrogen/Progestogen as Hormone Replacement TherapyStroke, 1998
- Hormone replacement therapy and risk of non-fatal strokeThe Lancet, 1997
- Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal WomenAnnals of Internal Medicine, 1992